|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:CASZ1-IPO13 (FusionGDB2 ID:13330) |
Fusion Gene Summary for CASZ1-IPO13 |
Fusion gene summary |
Fusion gene information | Fusion gene name: CASZ1-IPO13 | Fusion gene ID: 13330 | Hgene | Tgene | Gene symbol | CASZ1 | IPO13 | Gene ID | 54897 | 9670 |
Gene name | castor zinc finger 1 | importin 13 | |
Synonyms | CAS11|CST|SRG|ZNF693|dJ734G22.1 | IMP13|KAP13|LGL2|RANBP13 | |
Cytomap | 1p36.22 | 1p34.1 | |
Type of gene | protein-coding | protein-coding | |
Description | zinc finger protein castor homolog 1castor homolog 1, zinc fingercastor-related proteinsurvival-relatedzinc finger protein 693 | importin-13Ran binding protein 13karyopherin 13late gestation lung 2ran-binding protein 13 | |
Modification date | 20200313 | 20200327 | |
UniProtAcc | Q86V15 | O94829 | |
Ensembl transtripts involved in fusion gene | ENST00000377022, ENST00000344008, ENST00000478728, | ENST00000372343, ENST00000372339, ENST00000492152, | |
Fusion gene scores | * DoF score | 23 X 19 X 12=5244 | 4 X 4 X 3=48 |
# samples | 30 | 4 | |
** MAII score | log2(30/5244*10)=-4.12763327972587 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(4/48*10)=-0.263034405833794 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: CASZ1 [Title/Abstract] AND IPO13 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | CASZ1(10704973)-IPO13(44423648), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | CASZ1 | GO:0045893 | positive regulation of transcription, DNA-templated | 27693370 |
Tgene | IPO13 | GO:0006606 | protein import into nucleus | 15964792 |
Fusion gene breakpoints across CASZ1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across IPO13 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | ESCA | TCGA-Q9-A6FU | CASZ1 | chr1 | 10704973 | - | IPO13 | chr1 | 44423648 | + |
Top |
Fusion Gene ORF analysis for CASZ1-IPO13 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000377022 | ENST00000372343 | CASZ1 | chr1 | 10704973 | - | IPO13 | chr1 | 44423648 | + |
5CDS-intron | ENST00000377022 | ENST00000372339 | CASZ1 | chr1 | 10704973 | - | IPO13 | chr1 | 44423648 | + |
5CDS-intron | ENST00000377022 | ENST00000492152 | CASZ1 | chr1 | 10704973 | - | IPO13 | chr1 | 44423648 | + |
intron-3CDS | ENST00000344008 | ENST00000372343 | CASZ1 | chr1 | 10704973 | - | IPO13 | chr1 | 44423648 | + |
intron-intron | ENST00000344008 | ENST00000372339 | CASZ1 | chr1 | 10704973 | - | IPO13 | chr1 | 44423648 | + |
intron-intron | ENST00000344008 | ENST00000492152 | CASZ1 | chr1 | 10704973 | - | IPO13 | chr1 | 44423648 | + |
intron-3CDS | ENST00000478728 | ENST00000372343 | CASZ1 | chr1 | 10704973 | - | IPO13 | chr1 | 44423648 | + |
intron-intron | ENST00000478728 | ENST00000372339 | CASZ1 | chr1 | 10704973 | - | IPO13 | chr1 | 44423648 | + |
intron-intron | ENST00000478728 | ENST00000492152 | CASZ1 | chr1 | 10704973 | - | IPO13 | chr1 | 44423648 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000377022 | CASZ1 | chr1 | 10704973 | - | ENST00000372343 | IPO13 | chr1 | 44423648 | + | 5878 | 4186 | 285 | 5537 | 1750 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000377022 | ENST00000372343 | CASZ1 | chr1 | 10704973 | - | IPO13 | chr1 | 44423648 | + | 0.008232635 | 0.99176735 |
Top |
Fusion Genomic Features for CASZ1-IPO13 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
CASZ1 | chr1 | 10704973 | - | IPO13 | chr1 | 44423648 | + | 0.20686556 | 0.79313445 |
CASZ1 | chr1 | 10704973 | - | IPO13 | chr1 | 44423648 | + | 0.20686556 | 0.79313445 |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for CASZ1-IPO13 |
Go to FGviewer for the breakpoints of chr1:10704973-chr1:44423648 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
CASZ1 | IPO13 |
FUNCTION: Transcriptional activator (PubMed:23639441, PubMed:27693370). Involved in vascular assembly and morphogenesis through direct transcriptional regulation of EGFL7 (PubMed:23639441). {ECO:0000269|PubMed:23639441, ECO:0000269|PubMed:27693370}. | FUNCTION: Functions in nuclear protein import as nuclear transport receptor. Serves as receptor for nuclear localization signals (NLS) in cargo substrates. Is thought to mediate docking of the importin/substrate complex to the nuclear pore complex (NPC) through binding to nucleoporin and the complex is subsequently translocated through the pore by an energy requiring, Ran-dependent mechanism. At the nucleoplasmic side of the NPC, Ran binds to the importin, the importin/substrate complex dissociates and importin is re-exported from the nucleus to the cytoplasm where GTP hydrolysis releases Ran. The directionality of nuclear import is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus (By similarity). Mediates the nuclear import of UBC9, the RBM8A/MAGOH complex, PAX6 and probably other members of the paired homeobox family. Also mediates nuclear export of eIF-1A, and the cytoplasmic release of eIF-1A is triggered by the loading of import substrates onto IPO13. {ECO:0000250, ECO:0000269|PubMed:11447110, ECO:0000269|PubMed:15143176}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | CASZ1 | chr1:10704973 | chr1:44423648 | ENST00000377022 | - | 18 | 21 | 1080_1143 | 1289.3333333333333 | 1760.0 | Compositional bias | Note=Pro-rich |
Hgene | CASZ1 | chr1:10704973 | chr1:44423648 | ENST00000377022 | - | 18 | 21 | 384_417 | 1289.3333333333333 | 1760.0 | Compositional bias | Note=Pro-rich |
Hgene | CASZ1 | chr1:10704973 | chr1:44423648 | ENST00000377022 | - | 18 | 21 | 1031_1055 | 1289.3333333333333 | 1760.0 | Zinc finger | C2H2-type 4 |
Hgene | CASZ1 | chr1:10704973 | chr1:44423648 | ENST00000377022 | - | 18 | 21 | 551_575 | 1289.3333333333333 | 1760.0 | Zinc finger | C2H2-type 1 |
Hgene | CASZ1 | chr1:10704973 | chr1:44423648 | ENST00000377022 | - | 18 | 21 | 610_634 | 1289.3333333333333 | 1760.0 | Zinc finger | C2H2-type 2 |
Hgene | CASZ1 | chr1:10704973 | chr1:44423648 | ENST00000377022 | - | 18 | 21 | 668_692 | 1289.3333333333333 | 1760.0 | Zinc finger | C2H2-type 3 |
Tgene | IPO13 | chr1:10704973 | chr1:44423648 | ENST00000372343 | 6 | 20 | 524_558 | 513.3333333333334 | 964.0 | Repeat | HEAT 12 | |
Tgene | IPO13 | chr1:10704973 | chr1:44423648 | ENST00000372343 | 6 | 20 | 562_600 | 513.3333333333334 | 964.0 | Repeat | HEAT 13 | |
Tgene | IPO13 | chr1:10704973 | chr1:44423648 | ENST00000372343 | 6 | 20 | 603_648 | 513.3333333333334 | 964.0 | Repeat | HEAT 14 | |
Tgene | IPO13 | chr1:10704973 | chr1:44423648 | ENST00000372343 | 6 | 20 | 676_716 | 513.3333333333334 | 964.0 | Repeat | HEAT 15 | |
Tgene | IPO13 | chr1:10704973 | chr1:44423648 | ENST00000372343 | 6 | 20 | 720_754 | 513.3333333333334 | 964.0 | Repeat | HEAT 16 | |
Tgene | IPO13 | chr1:10704973 | chr1:44423648 | ENST00000372343 | 6 | 20 | 761_803 | 513.3333333333334 | 964.0 | Repeat | HEAT 17 | |
Tgene | IPO13 | chr1:10704973 | chr1:44423648 | ENST00000372343 | 6 | 20 | 815_845 | 513.3333333333334 | 964.0 | Repeat | HEAT 18 | |
Tgene | IPO13 | chr1:10704973 | chr1:44423648 | ENST00000372343 | 6 | 20 | 860_893 | 513.3333333333334 | 964.0 | Repeat | HEAT 19 | |
Tgene | IPO13 | chr1:10704973 | chr1:44423648 | ENST00000372343 | 6 | 20 | 897_931 | 513.3333333333334 | 964.0 | Repeat | HEAT 20 |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | CASZ1 | chr1:10704973 | chr1:44423648 | ENST00000344008 | - | 1 | 16 | 1080_1143 | 0 | 1167.0 | Compositional bias | Note=Pro-rich |
Hgene | CASZ1 | chr1:10704973 | chr1:44423648 | ENST00000344008 | - | 1 | 16 | 1635_1670 | 0 | 1167.0 | Compositional bias | Note=Ala-rich |
Hgene | CASZ1 | chr1:10704973 | chr1:44423648 | ENST00000344008 | - | 1 | 16 | 1672_1729 | 0 | 1167.0 | Compositional bias | Note=Glu-rich |
Hgene | CASZ1 | chr1:10704973 | chr1:44423648 | ENST00000344008 | - | 1 | 16 | 1691_1718 | 0 | 1167.0 | Compositional bias | Note=Asp-rich |
Hgene | CASZ1 | chr1:10704973 | chr1:44423648 | ENST00000344008 | - | 1 | 16 | 384_417 | 0 | 1167.0 | Compositional bias | Note=Pro-rich |
Hgene | CASZ1 | chr1:10704973 | chr1:44423648 | ENST00000377022 | - | 18 | 21 | 1635_1670 | 1289.3333333333333 | 1760.0 | Compositional bias | Note=Ala-rich |
Hgene | CASZ1 | chr1:10704973 | chr1:44423648 | ENST00000377022 | - | 18 | 21 | 1672_1729 | 1289.3333333333333 | 1760.0 | Compositional bias | Note=Glu-rich |
Hgene | CASZ1 | chr1:10704973 | chr1:44423648 | ENST00000377022 | - | 18 | 21 | 1691_1718 | 1289.3333333333333 | 1760.0 | Compositional bias | Note=Asp-rich |
Hgene | CASZ1 | chr1:10704973 | chr1:44423648 | ENST00000344008 | - | 1 | 16 | 1031_1055 | 0 | 1167.0 | Zinc finger | C2H2-type 4 |
Hgene | CASZ1 | chr1:10704973 | chr1:44423648 | ENST00000344008 | - | 1 | 16 | 1300_1324 | 0 | 1167.0 | Zinc finger | C2H2-type 5 |
Hgene | CASZ1 | chr1:10704973 | chr1:44423648 | ENST00000344008 | - | 1 | 16 | 1457_1481 | 0 | 1167.0 | Zinc finger | C2H2-type 6 |
Hgene | CASZ1 | chr1:10704973 | chr1:44423648 | ENST00000344008 | - | 1 | 16 | 1515_1537 | 0 | 1167.0 | Zinc finger | C2H2-type 7 |
Hgene | CASZ1 | chr1:10704973 | chr1:44423648 | ENST00000344008 | - | 1 | 16 | 1571_1595 | 0 | 1167.0 | Zinc finger | C2H2-type 8 |
Hgene | CASZ1 | chr1:10704973 | chr1:44423648 | ENST00000344008 | - | 1 | 16 | 551_575 | 0 | 1167.0 | Zinc finger | C2H2-type 1 |
Hgene | CASZ1 | chr1:10704973 | chr1:44423648 | ENST00000344008 | - | 1 | 16 | 610_634 | 0 | 1167.0 | Zinc finger | C2H2-type 2 |
Hgene | CASZ1 | chr1:10704973 | chr1:44423648 | ENST00000344008 | - | 1 | 16 | 668_692 | 0 | 1167.0 | Zinc finger | C2H2-type 3 |
Hgene | CASZ1 | chr1:10704973 | chr1:44423648 | ENST00000377022 | - | 18 | 21 | 1300_1324 | 1289.3333333333333 | 1760.0 | Zinc finger | C2H2-type 5 |
Hgene | CASZ1 | chr1:10704973 | chr1:44423648 | ENST00000377022 | - | 18 | 21 | 1457_1481 | 1289.3333333333333 | 1760.0 | Zinc finger | C2H2-type 6 |
Hgene | CASZ1 | chr1:10704973 | chr1:44423648 | ENST00000377022 | - | 18 | 21 | 1515_1537 | 1289.3333333333333 | 1760.0 | Zinc finger | C2H2-type 7 |
Hgene | CASZ1 | chr1:10704973 | chr1:44423648 | ENST00000377022 | - | 18 | 21 | 1571_1595 | 1289.3333333333333 | 1760.0 | Zinc finger | C2H2-type 8 |
Tgene | IPO13 | chr1:10704973 | chr1:44423648 | ENST00000372343 | 6 | 20 | 45_111 | 513.3333333333334 | 964.0 | Domain | Importin N-terminal | |
Tgene | IPO13 | chr1:10704973 | chr1:44423648 | ENST00000372343 | 6 | 20 | 142_179 | 513.3333333333334 | 964.0 | Repeat | HEAT 4 | |
Tgene | IPO13 | chr1:10704973 | chr1:44423648 | ENST00000372343 | 6 | 20 | 194_231 | 513.3333333333334 | 964.0 | Repeat | HEAT 5 | |
Tgene | IPO13 | chr1:10704973 | chr1:44423648 | ENST00000372343 | 6 | 20 | 236_268 | 513.3333333333334 | 964.0 | Repeat | HEAT 6 | |
Tgene | IPO13 | chr1:10704973 | chr1:44423648 | ENST00000372343 | 6 | 20 | 24_54 | 513.3333333333334 | 964.0 | Repeat | HEAT 1 | |
Tgene | IPO13 | chr1:10704973 | chr1:44423648 | ENST00000372343 | 6 | 20 | 276_325 | 513.3333333333334 | 964.0 | Repeat | HEAT 7 | |
Tgene | IPO13 | chr1:10704973 | chr1:44423648 | ENST00000372343 | 6 | 20 | 330_372 | 513.3333333333334 | 964.0 | Repeat | HEAT 8 | |
Tgene | IPO13 | chr1:10704973 | chr1:44423648 | ENST00000372343 | 6 | 20 | 375_438 | 513.3333333333334 | 964.0 | Repeat | HEAT 9 | |
Tgene | IPO13 | chr1:10704973 | chr1:44423648 | ENST00000372343 | 6 | 20 | 440_476 | 513.3333333333334 | 964.0 | Repeat | HEAT 10 | |
Tgene | IPO13 | chr1:10704973 | chr1:44423648 | ENST00000372343 | 6 | 20 | 487_522 | 513.3333333333334 | 964.0 | Repeat | HEAT 11 | |
Tgene | IPO13 | chr1:10704973 | chr1:44423648 | ENST00000372343 | 6 | 20 | 56_88 | 513.3333333333334 | 964.0 | Repeat | HEAT 2 | |
Tgene | IPO13 | chr1:10704973 | chr1:44423648 | ENST00000372343 | 6 | 20 | 95_135 | 513.3333333333334 | 964.0 | Repeat | HEAT 3 |
Top |
Fusion Gene Sequence for CASZ1-IPO13 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000377022_ENST00000372343_TCGA-Q9-A6FU_CASZ1_chr1_10704973_-_IPO13_chr1_44423648_length(transcript)=5878nt_BP=4186nt ATGCGCGCCCGCGGCGCTCCATCCCAAACACACACACATTTTTCCCCCGGACTTGGAAAGTCACCCAAAGCCGCCCCAAGTGCAGGCAAA CAGACCTTGCTGACTGAAGGCAAAGACTCCTCCATCCCACCTGCCCTCCCAGCTGCCACGGCCATCGACCCCTCCTTTACAAGGGGCTCC TGCAACTCCCCAGCAGCACGTGTTGGAATGGACTTCGGACCCTGGCCTCTTGGGATGCAAAGGATGAAGTGACACCCCCAGCTACATCCG AGGAGGTTCTAGGACCTGCTACGAGAGTTTGGGACCAAGGAGAAGAGAATGGATCTTGGAACAGCTGAGGGCACCCGGTGCACGGACCCG CCTGCAGGCAAGCCCGCCATGGCGCCCAAACGCAAGGGTGGCCTGAAGCTGAACGCCATCTGCGCCAAGCTGAGCCGCCAGGTGGTGGTG GAGAAGCGAGCTGACGCCGGCTCCCACACGGAGGGCAGCCCATCGCAGCCCCGGGACCAAGAGCGCAGTGGCCCTGAGTCTGGGGCAGCC CGGGCCCCCCGCAGCGAGGAAGACAAGAGACGGGCAGTGATCGAGAAGTGGGTGAACGGGGAGTACAGCGAGGAGCCGGCACCCACACCC GTGTTGGGGCGGATTGCCCGCGAGGGCCTGGAGCTGCCTCCCGAGGGTGTCTACATGGTGCAGCCCCAGGGGTGCAGCGATGAGGAAGAC CACGCGGAGGAGCCCTCCAAGGACGGCGGTGCCCTGGAGGAGAAGGATTCGGACGGGGCAGCCTCCAAGGAGGACAGCGGCCCCAGCACC AGGCAGGCTTCAGGAGAGGCCTCCTCGCTGCGGGACTACGCGGCCTCCACCATGACCGAGTTCCTCGGCATGTTTGGCTATGATGACCAG AACACGCGGGACGAGCTGGCCAGGAAGATCAGCTTTGAGAAGCTGCACGCGGGCTCCACCCCGGAGGCAGCCACCTCCTCCATGCTGCCC ACCTCCGAGGATACCCTCAGCAAGCGGGCGCGGTTCTCTAAGTATGAGGAGTACATCCGCAAGCTCAAGGCTGGCGAGCAGCTCTCCTGG CCGGCCCCCAGCACCAAGACCGAGGAGCGGGTGGGCAAGGAGGTGGTGGGCACCCTGCCCGGCCTGCGGCTGCCCAGCAGCACGGCCCAC CTGGAGACCAAGGCCACCATCCTGCCCCTGCCGTCGCACAGCAGTGTCCAGATGCAGAACCTGGTAGCCCGGGCCTCCAAGTACGACTTC TTCATCCAAAAACTGAAGACCGGCGAGAATCTGCGGCCCCAGAACGGGAGCACCTACAAGAAGCCATCCAAGTACGACCTGGAGAATGTC AAGTACCTGCACCTCTTCAAACCCGGGGAGGGCAGCCCCGACATGGGCGGGGCCATCGCCTTCAAGACAGGCAAGGTGGGGCGCCCTTCC AAGTACGACGTCCGGGGCATCCAGAAGCCAGGCCCCGCCAAGGTTCCGCCCACCCCCAGCCTGGCTCCCGCACCCCTCGCCAGCGTGCCC AGTGCCCCCAGCGCCCCCGGGCCAGGGCCAGAGCCTCCTGCCTCCCTGTCCTTCAACACTCCCGAGTACCTGAAGTCAACCTTCTCCAAA ACAGACTCCATCACCACGGGGACCGTCTCCACTGTCAAGAACGGACTGCCCACAGATAAACCAGCCGTCACTGAAGATGTAAACATTTAC CAGAAATATATTGCCAGGTTCTCGGGCAGCCAGCACTGTGGCCACATCCACTGTGCCTACCAGTACCGCGAGCACTACCACTGCCTTGAC CCTGAGTGTAACTACCAGAGGTTCACGAGTAAGCAGGACGTGATCCGCCACTACAACATGCACAAGAAGCGCGACAACTCCCTGCAGCAC GGCTTCATGCGTTTCAGCCCGCTGGACGACTGCAGCGTCTACTACCACGGCTGCCACCTCAATGGGAAGAGCACCCACTATCACTGCATG CAGGTGGGCTGTAACAAGGTGTACACGAGCACGTCTGACGTGATGACCCACGAGAACTTCCACAAGAAGAATACCCAGCTCATTAACGAC GGCTTCCAGCGCTTCCGAGCCACCGAAGACTGTGGCACAGCCGACTGCCAGTTCTACGGACAGAAGACCACGCACTTCCACTGCAGGCGC CCCGGCTGCACATTCACTTTCAAGAACAAGTGTGACATCGAGAAGCACAAGAGCTACCACATCAAGGACGATGCCTACGCCAAGGACGGC TTCAAGAAGTTCTACAAGTACGAGGAGTGCAAGTACGAGGGCTGCGTGTACAGCAAGGCTACCAACCACTTCCACTGCATCCGCGCCGGC TGCGGCTTCACCTTCACCTCCACCAGCCAGATGACCTCTCACAAGCGCAAGCATGAGCGCCGGCACATCCGCTCCTCGGGCGCGCTGGGG CTGCCGCCCTCGCTGCTGGGCGCCAAGGACACGGAGCACGAGGAGTCCAGCAACGACGACCTTGTTGACTTCTCCGCCCTGAGCAGCAAG AACTCCAGCCTGAGCGCCTCCCCTACCAGCCAGCAGTCCTCTGCGTCCCTGGCTGCCGCCACTGCCGCCACCGAGGCTGGGCCCAGTGCC ACCAAACCTCCCAACAGCAAGATCTCGGGGCTGCTGCCCCAGGGCCTGCCTGGCTCAATCCCCCTGGCCCTGGCCCTCTCCAACTCGGGC CTGCCCACCCCCACGCCCTACTTCCCCATACTGGCTGGCCGTGGGAGCACCTCCCTGCCTGTGGGCACCCCCAGCCTCCTGGGTGCCGTG TCGTCTGGGTCAGCAGCCTCAGCCACCCCTGACACACCCACGCTGGTCGCCTCGGGAGCTGGAGACTCAGCCCCCGTGGCTGCCGCCTCT GTCCCGGCACCACCCGCCTCCATCATGGAGAGGATCTCTGCAAGCAAGGGCCTCATCTCGCCCATGATGGCCAGGCTGGCTGCAGCTGCC CTCAAGCCCTCTGCCACCTTTGACCCAGGAAGCGGGCAGCAGGTCACCCCAGCCAGGTTCCCCCCGGCCCAAGTGAAGCCGGAACCCGGT GAGAGCACCGGCGCCCCAGGCCCCCACGAAGCCTCCCAGGACCGCAGTCTAGACCTGACTGTGAAGGAGCCCAGCAACGAATCAAATGGC CACGCAGTCCCGGCAAATTCATCTCTTTTATCCTCGCTTATGAATAAGATGTCTCAGGGCAACCCTGGCCTGGGCAGCCTGCTGAACATC AAGGCGGAAGCGGAGGGGAGCCCCGCTGCGGAGCCCTCGCCCTTCCTAGGCAAGGCCGTGAAGGCGCTGGTTCAGGAGAAGTTGGCAGAG CCCTGGAAGGTGTACCTGCGCAGGTTTGGTACAAAGGACTTCTGTGACGGCCAGTGTGACTTCCTCCACAAGGCCCACTTCCACTGCGTG GTGGAGGAATGCGGCGCGCTCTTCAGCACCTTGGACGGGGCCATCAAGCACGCAAACTTCCACTTCCGGACAGAGGGAGGAGCAGCAAAA GGAAACACAGAGGCTGCCTTTCCGGCCTCGGCCGCCGAGACCAAACCTCCCATGGCCCCCTCGTCCCCTCCGGTCCCTCCTGTCACCACG GCCACGGTGTCCTCTCTGGAGGGGCCCGCTCCCAGCCCGGCCTCCGTGCCCTCCACCCCCACCCTGCTCGCCTGGAAGCAGCTGGCTTCC ACCATACCCCAGATGCCTCAGATCCCAGCGTCAGTGCCTCACCTGCCCGCCTCGCCCTTGGCAACGACTTCTCTAGAGAACGCCAAGCCC CAGGTCAAACCCGGATTCCTCCAGTTCCAGGAGAACGATCCTTGCCTCGCCACGGACTGCAAGTACGCCAACAAGTTCCACTTCCACTGT CTCTTTGGGAACTGCAAGTACGTCTGCAAAACGTCTGGCAAGGCCGAATCCCACTGCCTGGACCACATCAACCCCAACAACAACCTGGTG AACGTGCGAGACCAGTTTGCATACTACTCTCTGCAGTGTCTCTGTCCCAACCAGCACTGCGAGTTCCGAATGCGTGGGCACTACCACTGC CTCCGCACCGGCTGCTATTTTGTGACCAACATCACCACCAAGCTCCCCTGGCACATCAAGAAGCATGAGAAGGCGGAGCGGCGGGCAGCC AATGGCTTCAAATACTTCACCAAGCGCGAGGAGTGTGGCAGGCTAGGAGCTCTGTCTGAATGGCTGGCTGACCACCCCGTCATGATCAAC AGTGTTCTGCCCTTGGTACTGCATGCCCTAGGCAATCCTGAGCTGTCTGTCTCTTCTGTGTCCACCCTCAAGAAGATCTGCCGAGAGTGC AAGTATGACCTGCCTCCCTATGCTGCCAACATTGTGGCTGTGTCCCAGGATGTGCTGATGAAACAGATCCACAAGACAAGCCAGTGCATG TGGCTGATGCAGGCGCTGGGCTTCCTGCTGTCAGCTCTTCAAGTGGAGGAGATCCTTAAGAACCTGCACTCGCTTATCTCACCCTATATC CAGCAACTGGAGAAGCTGGCAGAGGAGATACCCAATCCCTCCAACAAGCTGGCCATTGTTCACATCTTGGGGCTTCTCTCCAACCTCTTC ACCACACTGGACATCAGTCATCATGAGGATGATCATGAAGGCCCTGAGCTTCGGAAGCTGCCAGTGCCACAGGGACCCAACCCCGTGGTG GTGGTGCTGCAGCAGGTCTTCCAGCTTATCCAGAAGGTGCTGAGCAAATGGTTGAATGATGCCCAGGTTGTGGAGGCGGTGTGCGCTATC TTTGAGAAGTCTGTTAAGACGCTGCTGGATGACTTTGCCCCCATGGTGCCACAGCTGTGTGAGATGCTGGGTCGGATGTACAGCACCATC CCCCAGGCCTCTGCTCTTGACCTCACTCGACAGCTGGTCCACATCTTTGCTCATGAGCCTGCCCACTTTCCCCCAATTGAGGCCCTCTTC CTGCTCGTCACCTCCGTCACACTCACTCTCTTCCAGCAAGGGCCCAGGGATCATCCTGATATTGTTGATTCATTTATGCAACTCCTGGCA CAGGCTCTGAAGCGGAAGCCAGATTTGTTCCTGTGTGAACGATTGGATGTCAAAGCTGTGTTCCAGTGTGCTGTGCTGGCCCTCAAGTTC CCTGAGGCACCTACTGTCAAGGCCTCCTGTGGCTTCTTTACAGAGCTGCTGCCTCGGTGTGGGGAAGTAGAGTCTGTGGGAAAGGTGGTA CAGGAAGACGGTCGTATGCTGCTCATAGCAGTGCTGGAGGCCATTGGGGGCCAGGCCTCCCGCAGCCTCATGGACTGCTTTGCCGATATC CTGTTCGCCCTGAACAAGCACTGCTTCAGCCTCCTGAGCATGTGGATCAAGGAGGCCCTGCAGCCACCTGGTTTCCCCTCTGCCCGCCTC AGCCCTGAACAGAAGGATACCTTCAGCCAGCAGATCCTTCGCGAGCGAGTGAACAAGAGGCGGGTGAAGGAGATGGTGAAGGAGTTCACA CTGCTGTGCCGGGGTCTCCATGGCACAGATTACACAGCTGACTACTGAGGGGTGCCCCCATCCCATCCACCCCTTCTCTTCATCCTTCCC TATTCCCAAAGAGTAAACCTGGACCCTCACTGCTGTCTCTGCCTCCTTTCTGCTGTCACCACCACCTAACTGAAAGCCTGGGTCCAGAAG GCCTGGGGGAAGGATGGGAGGATGCTTGGACCCAGGCCTTGGGAGGGAATGGTGGGAACATCCTCTAGCTCCCAGGTTGGAAGAGATACT ACTGTAGCCAAGCCACCTAGGCTGGAGCCCTTCAGAATACTGTCATTGTCCTTGGGGCGGGGTGGTTGCAGTAGTGTCATCAACCCCCCC >In-frame_ENST00000377022_ENST00000372343_TCGA-Q9-A6FU_CASZ1_chr1_10704973_-_IPO13_chr1_44423648_length(amino acids)=1750AA_start in transcript=285_stop in transcript=5537 MLREFGTKEKRMDLGTAEGTRCTDPPAGKPAMAPKRKGGLKLNAICAKLSRQVVVEKRADAGSHTEGSPSQPRDQERSGPESGAARAPRS EEDKRRAVIEKWVNGEYSEEPAPTPVLGRIAREGLELPPEGVYMVQPQGCSDEEDHAEEPSKDGGALEEKDSDGAASKEDSGPSTRQASG EASSLRDYAASTMTEFLGMFGYDDQNTRDELARKISFEKLHAGSTPEAATSSMLPTSEDTLSKRARFSKYEEYIRKLKAGEQLSWPAPST KTEERVGKEVVGTLPGLRLPSSTAHLETKATILPLPSHSSVQMQNLVARASKYDFFIQKLKTGENLRPQNGSTYKKPSKYDLENVKYLHL FKPGEGSPDMGGAIAFKTGKVGRPSKYDVRGIQKPGPAKVPPTPSLAPAPLASVPSAPSAPGPGPEPPASLSFNTPEYLKSTFSKTDSIT TGTVSTVKNGLPTDKPAVTEDVNIYQKYIARFSGSQHCGHIHCAYQYREHYHCLDPECNYQRFTSKQDVIRHYNMHKKRDNSLQHGFMRF SPLDDCSVYYHGCHLNGKSTHYHCMQVGCNKVYTSTSDVMTHENFHKKNTQLINDGFQRFRATEDCGTADCQFYGQKTTHFHCRRPGCTF TFKNKCDIEKHKSYHIKDDAYAKDGFKKFYKYEECKYEGCVYSKATNHFHCIRAGCGFTFTSTSQMTSHKRKHERRHIRSSGALGLPPSL LGAKDTEHEESSNDDLVDFSALSSKNSSLSASPTSQQSSASLAAATAATEAGPSATKPPNSKISGLLPQGLPGSIPLALALSNSGLPTPT PYFPILAGRGSTSLPVGTPSLLGAVSSGSAASATPDTPTLVASGAGDSAPVAAASVPAPPASIMERISASKGLISPMMARLAAAALKPSA TFDPGSGQQVTPARFPPAQVKPEPGESTGAPGPHEASQDRSLDLTVKEPSNESNGHAVPANSSLLSSLMNKMSQGNPGLGSLLNIKAEAE GSPAAEPSPFLGKAVKALVQEKLAEPWKVYLRRFGTKDFCDGQCDFLHKAHFHCVVEECGALFSTLDGAIKHANFHFRTEGGAAKGNTEA AFPASAAETKPPMAPSSPPVPPVTTATVSSLEGPAPSPASVPSTPTLLAWKQLASTIPQMPQIPASVPHLPASPLATTSLENAKPQVKPG FLQFQENDPCLATDCKYANKFHFHCLFGNCKYVCKTSGKAESHCLDHINPNNNLVNVRDQFAYYSLQCLCPNQHCEFRMRGHYHCLRTGC YFVTNITTKLPWHIKKHEKAERRAANGFKYFTKREECGRLGALSEWLADHPVMINSVLPLVLHALGNPELSVSSVSTLKKICRECKYDLP PYAANIVAVSQDVLMKQIHKTSQCMWLMQALGFLLSALQVEEILKNLHSLISPYIQQLEKLAEEIPNPSNKLAIVHILGLLSNLFTTLDI SHHEDDHEGPELRKLPVPQGPNPVVVVLQQVFQLIQKVLSKWLNDAQVVEAVCAIFEKSVKTLLDDFAPMVPQLCEMLGRMYSTIPQASA LDLTRQLVHIFAHEPAHFPPIEALFLLVTSVTLTLFQQGPRDHPDIVDSFMQLLAQALKRKPDLFLCERLDVKAVFQCAVLALKFPEAPT VKASCGFFTELLPRCGEVESVGKVVQEDGRMLLIAVLEAIGGQASRSLMDCFADILFALNKHCFSLLSMWIKEALQPPGFPSARLSPEQK -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for CASZ1-IPO13 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for CASZ1-IPO13 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for CASZ1-IPO13 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | CASZ1 | C0004238 | Atrial Fibrillation | 2 | CTD_human |
Hgene | CASZ1 | C0235480 | Paroxysmal atrial fibrillation | 2 | CTD_human |
Hgene | CASZ1 | C2585653 | Persistent atrial fibrillation | 2 | CTD_human |
Hgene | CASZ1 | C3468561 | familial atrial fibrillation | 2 | CTD_human |
Hgene | CASZ1 | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
Hgene | CASZ1 | C0038454 | Cerebrovascular accident | 1 | CTD_human |
Hgene | CASZ1 | C0376358 | Malignant neoplasm of prostate | 1 | CTD_human |
Hgene | CASZ1 | C0751956 | Acute Cerebrovascular Accidents | 1 | CTD_human |